The Effect of Controlled Release of PDGF-BB from Heparin-conjugated Electrospun PCL/gelatin Scaffolds on Cellular Bioactivity and Infiltration

Overview

Journal Biomaterials

Specialty Biomedical Engineering

Date 2012 Jul 10

PMID 22770570

Citations 37

Authors

Jongman Lee

James J Yoo

Anthony Atala

Sang Jin Lee

Affiliations

Soon will be listed here.

Abstract

Heparin-conjugated electrospun poly(ε-caprolactone) (PCL)/gelatin scaffolds were developed to provide controlled release of platelet-derived growth factor-BB (PDGF-BB) and allow prolonged bioactivity of this molecule. A mixture of PCL and gelatin was electrospun into three different morphologies. Next, heparin molecules were conjugated to the reactive surface of the scaffolds. This heparin-conjugated scaffold allowed the immobilization of PDGF-BB via electrostatic interaction. In vitro PDGF-BB release profiles indicated that passive physical adsorption of PDGF-BB to non-heparinized scaffolds resulted in an initial burst release of PDGF-BB within 5 days, which then leveled off. However, electrostatic interaction between PDGF-BB and the heparin-conjugated scaffolds gave rise to a sustained release of PDGF-BB over the course of 20 days without an initial burst. Moreover, PDGF-BB that was strongly bound to the heparin-conjugated scaffolds enhanced smooth muscle cell (SMC) proliferation. In addition, scaffolds composed of 3.0 μm diameter fibers that were immobilized with PDGF-BB accelerated SMC infiltration into the scaffold when compared to scaffolds composed of smaller diameter fibers or scaffolds that did not release PDGF-BB. We concluded that the combination of the large pore structure in the scaffolds and the heparin-mediated delivery of PDGF-BB provided the most effective cellular interactions through synergistic physical and chemical cues.

Citing Articles

Bioactive peptides and proteins for tissue repair: microenvironment modulation, rational delivery, and clinical potential.

Hao Z, Zhang Z, Wang Z, Wang Y, Chen J, Chen T Mil Med Res. 2024; 11(1):75.

PMID: 39639374 PMC: 11619216. DOI: 10.1186/s40779-024-00576-x.

Osteoinductivity enhancement by tailoring the surface chemical bond status: A strategy to mobilize host bone growth factors for bone regeneration.

Li R, Zhang K, Dong C, Wang K, Gu X, Qin Y Mater Today Bio. 2024; 29:101256.

PMID: 39381265 PMC: 11460471. DOI: 10.1016/j.mtbio.2024.101256.

Development of a Composite Hydrogel Containing Statistically Optimized PDGF-Loaded Polymeric Nanospheres for Skin Regeneration: In Vitro Evaluation and Stem Cell Differentiation Studies.

Hazrati R, Alizadeh E, Soltani S, Keyhanvar P, Davaran S ACS Omega. 2024; 9(13):15114-15133.

PMID: 38585049 PMC: 10993260. DOI: 10.1021/acsomega.3c09391.

Investigations into the effects of scaffold microstructure on slow-release system with bioactive factors for bone repair.

Pei B, Hu M, Wu X, Lu D, Zhang S, Zhang L Front Bioeng Biotechnol. 2023; 11:1230682.

PMID: 37781533 PMC: 10537235. DOI: 10.3389/fbioe.2023.1230682.

Fabrication of polycaprolactone electrospun fibres with retinyl acetate for antioxidant delivery in a ROS-mimicking environment.

Westwood L, Emmerson E, Callanan A Front Bioeng Biotechnol. 2023; 11:1233801.

PMID: 37650040 PMC: 10463743. DOI: 10.3389/fbioe.2023.1233801.

References

Szentivanyi A, Chakradeo T, Zernetsch H, Glasmacher B . Electrospun cellular microenvironments: Understanding controlled release and scaffold structure. Adv Drug Deliv Rev. 2010; 63(4-5):209-20. DOI: 10.1016/j.addr.2010.12.002. View

Lee J, Yoo J, Atala A, Lee S . Controlled heparin conjugation on electrospun poly(ε-caprolactone)/gelatin fibers for morphology-dependent protein delivery and enhanced cellular affinity. Acta Biomater. 2012; 8(7):2549-58. DOI: 10.1016/j.actbio.2012.03.030. View

Welsh C, Schmeichel K, McBride K . Platelet-derived growth factor activates phospholipase D and chemotactic responses in vascular smooth muscle cells. In Vitro Cell Dev Biol. 1991; 27A(5):425-31. DOI: 10.1007/BF02630963. View

Sun B, Chen B, Zhao Y, Sun W, Chen K, Zhang J . Crosslinking heparin to collagen scaffolds for the delivery of human platelet-derived growth factor. J Biomed Mater Res B Appl Biomater. 2009; 91(1):366-72. DOI: 10.1002/jbm.b.31411. View

Nillesen S, Geutjes P, Wismans R, Schalkwijk J, Daamen W, van Kuppevelt T . Increased angiogenesis and blood vessel maturation in acellular collagen-heparin scaffolds containing both FGF2 and VEGF. Biomaterials. 2006; 28(6):1123-31. DOI: 10.1016/j.biomaterials.2006.10.029. View

Prestrelski S, Fox G, Arakawa T . Binding of heparin to basic fibroblast growth factor induces a conformational change. Arch Biochem Biophys. 1992; 293(2):314-9. DOI: 10.1016/0003-9861(92)90401-h. View

Castellot Jr J, Wong K, Herman B, Hoover R, Albertini D, Wright T . Binding and internalization of heparin by vascular smooth muscle cells. J Cell Physiol. 1985; 124(1):13-20. DOI: 10.1002/jcp.1041240104. View

Mangrulkar R, Ono M, Ishikawa M, Takashima S, Klagsbrun M, Nowak R . Isolation and characterization of heparin-binding growth factors in human leiomyomas and normal myometrium. Biol Reprod. 1995; 53(3):636-46. DOI: 10.1095/biolreprod53.3.636. View

Nam J, Huang Y, Agarwal S, Lannutti J . Improved cellular infiltration in electrospun fiber via engineered porosity. Tissue Eng. 2007; 13(9):2249-57. PMC: 4948987. DOI: 10.1089/ten.2006.0306. View

10.

Pieper J, Hafmans T, van Wachem P, Van Luyn M, Brouwer L, Veerkamp J . Loading of collagen-heparan sulfate matrices with bFGF promotes angiogenesis and tissue generation in rats. J Biomed Mater Res. 2002; 62(2):185-94. DOI: 10.1002/jbm.10267. View

11.

Balguid A, Mol A, van Marion M, Bank R, Bouten C, Baaijens F . Tailoring fiber diameter in electrospun poly(epsilon-caprolactone) scaffolds for optimal cellular infiltration in cardiovascular tissue engineering. Tissue Eng Part A. 2008; 15(2):437-44. DOI: 10.1089/ten.tea.2007.0294. View

12.

Huang X, Brazel C . On the importance and mechanisms of burst release in matrix-controlled drug delivery systems. J Control Release. 2001; 73(2-3):121-36. DOI: 10.1016/s0168-3659(01)00248-6. View

13.

Pham Q, Sharma U, Mikos A . Electrospun poly(epsilon-caprolactone) microfiber and multilayer nanofiber/microfiber scaffolds: characterization of scaffolds and measurement of cellular infiltration. Biomacromolecules. 2006; 7(10):2796-805. DOI: 10.1021/bm060680j. View

14.

Nie H, Ho M, Wang C, Wang C, Fu Y . BMP-2 plasmid loaded PLGA/HAp composite scaffolds for treatment of bone defects in nude mice. Biomaterials. 2008; 30(5):892-901. DOI: 10.1016/j.biomaterials.2008.10.029. View

15.

Lee J, Choi W, Tae G, Kim Y, Kang S, Kim S . Enhanced regeneration of the ligament-bone interface using a poly(L-lactide-co-ε-caprolactone) scaffold with local delivery of cells/BMP-2 using a heparin-based hydrogel. Acta Biomater. 2010; 7(1):244-57. DOI: 10.1016/j.actbio.2010.08.017. View

16.

Sill T, von Recum H . Electrospinning: applications in drug delivery and tissue engineering. Biomaterials. 2008; 29(13):1989-2006. DOI: 10.1016/j.biomaterials.2008.01.011. View

17.

GOSPODAROWICZ D, Cheng J . Heparin protects basic and acidic FGF from inactivation. J Cell Physiol. 1986; 128(3):475-84. DOI: 10.1002/jcp.1041280317. View

18.

Walker A, Turnbull J, Gallagher J . Specific heparan sulfate saccharides mediate the activity of basic fibroblast growth factor. J Biol Chem. 1994; 269(2):931-5. View

19.

Park Y, Lee Y, Lee J, Seol Y, Chung C, Lee S . Controlled release of platelet-derived growth factor-BB from chondroitin sulfate-chitosan sponge for guided bone regeneration. J Control Release. 2000; 67(2-3):385-94. DOI: 10.1016/s0168-3659(00)00232-7. View

20.

Chakraborty S, Liao I, Adler A, Leong K . Electrohydrodynamics: A facile technique to fabricate drug delivery systems. Adv Drug Deliv Rev. 2009; 61(12):1043-54. PMC: 2761154. DOI: 10.1016/j.addr.2009.07.013. View